Purchase Order 75N94024P00536
Award Date
8/12/24
Potential Completion Date
10/14/24
Potential Value
$15K
Funding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Contracting Federal Agency
National Institute of Child Health and Human Development
Awardee
Twist Bioscience Corporation
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Twist Bioscience Corporation has been awarded a firm fixed price purchase order contract valued at $24,285 by the National Institutes of Health's National Institute of Neurological Disorders and Stroke to provide a custom single site variant library. As the prime contractor, Twist Bioscience will deliver the requested synthetic DNA products to support genomics research efforts. No set aside designation was applied to this award. Twist Bioscience is a manufacturer of synthetic DNA based in...
This is a firm fixed price purchase order valued at $22,400.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation for DNA synthesis services to support gene cloning. The contract has no set-aside designation and the ultimate completion date is December 31, 2024. Twist Bioscience is a synthetic biology company that specializes in manufacturing high-quality synthetic DNA and has...
This federal contract award to Twist Bioscience Corporation, a synthetic biology company in South San Francisco, CA, is for the delivery of COVID-19 DNA constructs. The $29,671.85 firm fixed price purchase order was awarded on June 4, 2020 by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the National Institutes of Health (NIH). The contract does not have a set-aside designation. Through this award, as well as previous contracts and grants, Twist...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The $97,588 contract is for the provision of COVID-19 DNA constructs, which likely support genomics research, disease surveillance, and public health initiatives. This contract does not have a set-aside designation. Twist...
The Department of Health and Human Services' National Institutes of Health National Institute on Aging awarded a $77,874 purchase order to Twist Bioscience Corporation of South San Francisco, California. Under the firm fixed price contract, Twist Bioscience will provide custom cloned pooled oligo libraries in support of the NIH NIA's biomedical research efforts. The contract runs from July 10, 2023 through August 31, 2023 and represents a small purchase awarded directly to the prime contractor...
This is a $14,031.25 firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for Twist Bioscience to provide a custom capture panel to support a new blood-based cancer diagnostic that will detect human herpesvirus 8 (HHV8) in the plasma of HIV patients. The award has an ultimate completion date of October 31, 2024 and was made on August...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a firm fixed price purchase order to Twist Bioscience Corporation, a for-profit synthetic biology company, to provide TWIST RNA products for the FLUSC2 MULTIPLE program. The $51,160.00 contract does not have a set-aside designation and is scheduled for completion by April 30, 2024. Twist Bioscience, a manufacturer of goods, has previously received numerous federal contracts to supply synthetic...
This firm fixed price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract, valued at $578,224.78, is for the delivery of SC2 POSITIVE CONTROL SYNTHETIC RNA CONTROL MATERIAL. This contract is not associated with a set-aside program. Twist Bioscience has been awarded numerous federal contracts, primarily as a prime contractor, to provide synthetic DNA...
This is a $5,019,966 firm fixed price contract awarded by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH) to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California. The contract is for the development of a portable, rapid, and disposable COVID-19 diagnostic test using synthetic antibodies, known as the RADX TECH PROJECT 6818. This contract does not have a set-aside designation. Twist Bioscience has...
This is a federal contract award to Twist Bioscience Corporation, a synthetic biology company based in South San Francisco, California, for the provision of SARS-CoV-2 RNA controls. The contract, valued at $82,080.66, was awarded by the Centers for Disease Control and Prevention (CDC) on July 29, 2020 and has an ultimate completion date of August 29, 2020. The contract is a firm fixed price purchase order and does not have a set-aside designation. Twist Bioscience has been a key provider of...